Functional changes in neuronal systems induced by phencyclidine administration

Annals of the New York Academy of Sciences

Volumn 801, Issue , 1996, Pages 29-38

  Nabeshima, Toshitaka ^a   Kitaichi, Kiyoyuki ^a   Noda, Yukihiro ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; HALOPERIDOL; METHYSERGIDE; NITRIC OXIDE; PHENCYCLIDINE; RISPERIDONE; RITANSERIN; SEROTONIN 2A RECEPTOR; SIGMA OPIATE RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; AVERSION; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG DEPENDENCE; DRUG EFFECT; GENE EXPRESSION; HYPERACTIVITY; IMMEDIATE EARLY GENE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEUROCHEMISTRY; NONHUMAN; PLACE PREFERENCE; RAT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; STEREOTYPY; WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0030447503     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb17429.x     Document Type: Conference Paper

References (54)

1. CHENS, G., C. R. ENSOR, D. RUSSEL & B. BOHNER. 1959. The pharmacology of 1-(1-phenylcyclohexyl)piperadine-HCl. J. Pharmacol. Exp. Ther. 127: 241-450.
2. PETERSENM, R. C. & R. C. STILLMAN. 1978. Phencyclidine abuse: An appraisal. National Institute of Drug Abuse Research Monograph 21: 1-17. United States Department of Health, Education and Welfare.
3. ISSACS, S. O., P. MARTIN & J. A. WASHINGTON. 1986. Phencyclidine (PCP) abuse. Oral Surg. Oral Med. Oral Pathol. 61: 126-129.
4. THOMBS, D. L. 1989. A review of PCP abuse trends and perceptions. Public Health Rep. 104: 325-328.
5. CASTELLANI, S. & P. M. ADAMS. 1981. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur. J. Pharmacol. 73: 143-154.
6. NABESHIMA, T., K. YAMAGUCHI, K. YAMADA, M. HIRAMATSU, H. FURUKAWA & T. KAMEYAMA. 1983. Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesion of the striatum. Eur. J. Pharmacol. 93: 229-234.
7. NABESHIMA, T., K. YAMADA, K. YAMAGUCHI, M. HIRAMATSU, H. FURUKAWA & T. KAMEYAMA. 1983. Effect of lesions in the striatum, nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats. Eur. J. Pharmacol. 91: 455-462.
8. NABESHIMA, T., K. ISHIKAWA, K. YAMAGUCHI, H. FURUKAWA & T. KAMEYAMA. 1986. Methysergide-induced precipitated withdrawal syndrome in phencyclidine-dependent rats. Neurosci. Lett. 69: 275-278.
9. OGAWA, S., S. OKUYAMA, H. ARAKI & S. OTOMO. 1994. Effect of NE-100, a novel σ receptor ligand, on phencyclidine-induced cognitive dysfunction. Eur. J. Pharmacol. 263: 9-15.
10. TRULLAS, R. & P. SKOLNICK. 1990. Functional antagonists at NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol. 185: 1-10.
11. 1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur. J. Pharmacol. 169: 1-10.
12. SHANNON, H. E. 1981. Evaluation of phencyclidine analogs on the basis of their disciminative properties in rats. J. Pharmacol. Exp. Ther. 216: 543-551.
13. POLONG, A., J. CLEARY, K. JACKSON & S. WALLACE. 1981. D-Amphetamine and phencyclidine alone and in combination: effects on fixed-ratio and interresponse-time-greater-than-t responding of rats. Pharmacol. Biochem. Behav. 15: 357-361.
14. JONES, S. M., L. D. SNELL & K. M. JOHNSON. 1987. Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens. Neuropharmacology 26: 173-179.
15. JAVITT, D. C. & S. R. ZUKIN. 1991. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148: 1301-1308.
16. 3H]-1-[1-(2-thienyl)cyclohexyl]piperidine. J. Pharmacol. Exp. Ther. 238: 739-748.
17. 3H]norepinephrine release. J. Pharmacol. Exp. Ther. 240: 492-497.
18. WROBLEWSKI, J. T., F. NICOLETTI, E. FADA & E. COSTA. 1987. Phencyclidine is a negative allosteric modulator of signal transduction at two subclasses of excitatory amino acid receptors. Proc. Natl. Acad. Sci. U.S.A. 84: 5068-5072.
19. VICKROY, T. W. & K. M. JOHNSON. 1982. Similar dopamine-releasing effects of phencyclidine and nonamphetamine stimulants in striatal slices. J. Pharmacol. Exp. Ther. 223: 669-674.
20. IMPERATO, A., T. HONORÂ & L. H. JENSSEN. 1990. Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats. Brain Res. 530: 223-228.
21. STEINPREIS, R. E. & J. D. SALAMONE. 1993. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Res. 612: 263-270.
22. GAREY, R. E., L. A. WEISBERG & R. G. HEATH. 1979. PCP (phencyclidine): an update. J. Psych. Drugs 9: 280-285.
23. 3H]serotonin uptake in synaptosomal preparations from rat brain. Biochem. Pharmacol. 26: 1435-1439.
24. 3H-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine. J. Neurosci. 6: 1757-1770.
25. SONDERS, M. S., J. F. W. KEANA & E. WEBER. 1988. Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. Trends Neurosci. 11: 37-40.
26. NABESHIMA, T., Y. NODA, K. YAMAGUCHI, K. ISHIKAWA, H. FURUKAWA & T. KAMEYAMA. 1985. Acute and chronic phencyclidine changes serotonin receptors in rat brain. Eur. J. Pharmacol. 109: 129-132.
27. PILOTTE, N. S., L. G. SHARPE & M. J. KUHAR. 1994. Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats. J. Pharmacol. Exp. Ther. 269: 963-969.
28. PESCE, M. E., X. ACEVEDO, G. PINARDI & H. F. MIRANDA. 1994. Gender differences in diazepam withdrawal syndrome in mice. Pharmacol. Toxicol. 75: 353-355.
29. TENNANT, F. S., JR., R. A. RAWSON & M. MCCANN. 1981. Withdrawal from chronic phencyclidine (PCP) dependence with desipramine. Am. J. Psychiatry 138: 845-847.
30. 1B receptor subtypes in rat frontal cortex. J. Pharmacol. Exp. Ther. 231: 480-487.
31. 2 receptor binding agent. Curr. Ther. Res. 40: 492-499.
32. KITAICHI, K., K. YAMADA, T. HASEGAWA, H. FURUKAWA & T. NABESHIMA. 1994. Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. Jpn. J. Pharmacol. 66: 181-189.
33. 2 receptor, but not serotonin, receptor. Res. Commun. Subst. Abuse. 5: 81-87.
34. GIANNINI, A. J., R. H. LOISELLE, B. H. GRAHAM & D. J. FOLTS. 1993. Behavioral response to buspirone in cocaine and phencyclidine withdrawal. J. Subst. Abuse. Treat. 10: 523-527.
35. FISCHMAN, M. W. 1987. Cocaine and the amphetamine. In Psychopharmacology. H. Y. Melzer, Eds.: 1543-1553. Raven Press. New York, NY.
36. GRIFFITHS, R. R. & C. A. SANNERUD. 1987. Abuse of and dependence on benzodiazepines and other anxiolytic sedative drugs. In Psychopharmacology. H. Y. Melzer, Eds.: 1535-1541. Raven Press. New York, NY.
37. NABESHIMA, T., H. FUKAYA, K. YAMAGUCHI, K. ISHIKAWA, H. FURUKAWA & T. KAMAYAMA. 1987. Development of tolerance and supersenstivity to phencyclidine in rats after repeated administration of phencyclidine. Eur. J. Pharmacol. 135: 23-33.
38. KITAICHI, K., K. YAMADA, Y. YONEDA, K. OGITA, T. HASEGAWA, H. FURUKAWA & T. NABESHIMA. 1995. Risperidone prevents the development of supersensitivity, but not tolerance, to phencyclidine in rats treated with subacute phencyclidine. Life Sci. 56: 531-543.
39. NODA, Y., K. YAMADA, Y. KOMORI, H. SUGIHARA, H. FURUKAWA & T. NABESHIMA. 1996. Role of nitric oxide in the development of tolerance and sensitization to behavioral effects of phencyclidine in mice. Br. J. Pharmacol. 117: 1579-1585.
40. IZUMI, Y., D. B. CLIFFORD & C. F. ZORUMSKI. 1992. Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. Science 257: 1273-1276.
41. LUM-RAGEN, J. T. & V. K. GRIBKOFF. 1993. The sensitivity of hippocampal long-term potentiation to nitric oxide synthase inhibitors is dependent upon the pattern of conditioning stimulation. Neuroscience 57: 973-983.
42. REIF, G. W. 1993. Delayed production of nitric oxide contributes to NMDA-mediated neuronal damage. Neuroreport 4: 566-568.
43. RAUHALA, P., J. J. IDÄNPÄÄN-HEIKKILÄ, R. K. TUOMINEN & P. T. MÄNNISTO. 1994. N-nitro-L-arginine attenuates development of tolerance to antinociceptive but not to hormonal effects of morphine. Eur. J. Pharmacol. 258: 57-64.
44. PUDIAK, C. M. & M. A. BOZARTH. 1993. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci. 53: 1517-1524.
45. SCHECHTER, M. D. & D. J. CALCAGNETTI. 1993. Trends in place preference conditioning with a cross-indexed bibliography; 1957-1991. Neurosci. Biobehav. Rev. 17: 21-41.
46. BARR, G. A., W. PAREDES & W. H. BRIDGER. 1985. Place conditioning with morphine and phencyclidine; dose dependent effects. Life Sci. 36: 363-368.
47. IWAMOTO, E. T. 1986. Place-conditioning properties of mu, kappa, and sigma opioid agonists. Alcohol Drug Res. 6: 327-339.
48. KITAICHI, K., A. NUMAGUCHI, T. HASEGAWA, H. FURUKAWA & T. NABESHIMA. 1995. Effects of phencyclidine on the condition place preference. Folia Pharmacol. Jpn. 105: 61P.
49. OKUYAMA, S., Y. IMAGAWA, S. OGAWA, H. ARAKI, M. TANAKA, M. MURAMATSU, A. NAKAZATO, K. YAMAGUCHI, M. YOSHIDA & S. OTOMO. 1993. NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci. 53: PL285-PL290.
50. KITAICHI, K., H. OSAWA, A. NUMAGUCHI, T. HASEGAWA, H. FURUKAWA & T. NABESHIMA. 1995. Decrease of intensity in phencyclidine-induced place aversion in rats treated with subacute phencyclidine Jpn. J. Pharmacol. 67(supple. I): 142P.
51. SUGITA, S., M. NAMIMA, T. NABESHIMA, H. FURUKAWA & Y. WATANABE. 1994. The ambulatory activity and the cerebral expression of c-Fos- and c-Jun-like immunoreactivities in mice acutely treated with phencyclidine. Folia Pharmacol. Jpn. 105: 33P.
52. MIDGLEY, L. P., L. G. BUSH, L. W. GIBB & G. R. HANSON. 1992. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate putamen. Brain Res. 593: 89-96.
53. MIDGLEY, L. P., L. G. BUSH, L. W. GIBB & G. R. HANSON. 1993. Differential regulation of neuropeptide Y systems in limbic structures of the rat. J. Pharmacol. Exp. Ther. 267: 707-713.
54. MITSUSHIO, H., Y. SHIRAYAMA, T. NISHIKAWA & K. TAKAHASHI. 1993. Effects of subacute repeated injection of phencyclidine and MK-801 on substance P content in the rat brain. Regul. Pept. 46: 352-353.